96 related articles for article (PubMed ID: 19460734)
1. [Sorafenib reverses multidrug resistance of hepatoma cells in vitro].
Wei L; Huang N; Yang L; Zheng DY; Cui YZ; Li AM; Lü CW; Zheng H; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):1016-9, 1023. PubMed ID: 19460734
[TBL] [Abstract][Full Text] [Related]
2. [Reversion of drug-resistant hepatocellular carcinoma cell line BEL-7402/FU by sorafenib].
Wei L; Su N; Zheng DY; Cao MR; Li AM; Yan X; Lü CW; Luo RC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):344-7. PubMed ID: 19351508
[TBL] [Abstract][Full Text] [Related]
3. The noncytotoxic dose of sorafenib sensitizes Bel-7402/5-FU cells to 5-FU by down-regulating 5-FU-induced Nrf2 expression.
Zhou S; Ye W; Duan X; Zhang M; Wang J
Dig Dis Sci; 2013 Jun; 58(6):1615-26. PubMed ID: 23314856
[TBL] [Abstract][Full Text] [Related]
4. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
[TBL] [Abstract][Full Text] [Related]
5. [Impact of epigallocatechin gallate on gene expression profiles of human hepatocellular carcinoma cell lines BEL7404/ADM and BEL7402/5-FU].
Tang HH; Zhou M; Liang G
Ai Zheng; 2008 Oct; 27(10):1056-64. PubMed ID: 18851785
[TBL] [Abstract][Full Text] [Related]
6. Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.
Shi LX; Ma R; Lu R; Xu Q; Zhu ZF; Wang L; Zhou CL; Li XL; Zhang HL; Yao Z
Cancer Lett; 2008 Sep; 269(1):101-10. PubMed ID: 18538471
[TBL] [Abstract][Full Text] [Related]
7. [Effects of chloroquine in reversing multidrug resistance in HNE1/DDP cell line].
Zhang H; Sun X; Sun Y; Zhao S; Jiang C; Liu H
Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):687-91. PubMed ID: 26018263
[TBL] [Abstract][Full Text] [Related]
8. Reversal effect of Tween-20 on multidrug resistance in tumor cells in vitro.
Yang S; Liu J; Chen Y; Jiang J
Biomed Pharmacother; 2012 Apr; 66(3):187-94. PubMed ID: 22440896
[TBL] [Abstract][Full Text] [Related]
9. Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P-glycoprotein.
Xiang QF; Zhang DM; Wang JN; Zhang HW; Zheng ZY; Yu DC; Li YJ; Xu J; Chen YJ; Shang CZ
Liver Int; 2015 Mar; 35(3):1010-23. PubMed ID: 24621440
[TBL] [Abstract][Full Text] [Related]
10. The Effects and Mechanisms of Periplaneta americana Extract Reversal of Multi-Drug Resistance in BEL-7402/5-FU Cells.
Yuan F; Liu J; Qiao T; Li T; Shen Q; Peng F
Molecules; 2016 Jun; 21(7):. PubMed ID: 27367657
[TBL] [Abstract][Full Text] [Related]
11. Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II.
Huang C; Xu D; Xia Q; Wang P; Rong C; Su Y
J Pharm Pharmacol; 2012 Dec; 64(12):1741-50. PubMed ID: 23146037
[TBL] [Abstract][Full Text] [Related]
12. Role of sorafenib and sunitinib in the induction of expressions of NKG2D ligands in nasopharyngeal carcinoma with high expression of ABCG2.
Huang Y; Wang Y; Li Y; Guo K; He Y
J Cancer Res Clin Oncol; 2011 May; 137(5):829-37. PubMed ID: 20809412
[TBL] [Abstract][Full Text] [Related]
13. [Reversal of multidrug resistance of human hepatocellular carcinoma cells by wild-type p53 gene and related mechanisms].
Gai XD; Li GL; Huang JZ; Xue HJ; Wang D
Ai Zheng; 2006 Aug; 25(8):954-9. PubMed ID: 16965674
[TBL] [Abstract][Full Text] [Related]
14. [Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene].
Li L; Wang T; Xu ZL; Yu Y; Chen W; Chen F
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1633-7. PubMed ID: 16185533
[TBL] [Abstract][Full Text] [Related]
15. [Schedule-dependent effects of sorafenib in combination with paclitaxel on human hepatocellular carcinoma cell line BEL-7402].
Li N; Zhang Y; Wu T; Li M
Ai Zheng; 2009 Aug; 28(8):838-43. PubMed ID: 19664330
[TBL] [Abstract][Full Text] [Related]
16. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
Gao A; Wang X; Xiang W; Liang H; Gao J; Yan Y
J Pharm Pharmacol; 2010 Mar; 62(3):393-9. PubMed ID: 20487225
[TBL] [Abstract][Full Text] [Related]
17. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
[TBL] [Abstract][Full Text] [Related]
18. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells.
Dong J; Zhai B; Sun W; Hu F; Cheng H; Xu J
PLoS One; 2017; 12(9):e0185088. PubMed ID: 28934275
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression.
Huang YS; Xue Z; Zhang H
Med Oncol; 2015 Feb; 32(2):470. PubMed ID: 25579168
[TBL] [Abstract][Full Text] [Related]
20. [Study on the mechanism of reversing multidrug resistance of hepatocarcinoma by bromocriptine].
Ding L; Chen XP; Zhang ZW; Zhang WG; Cao B; Wang ZH; Li CL
Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):353-7. PubMed ID: 16732910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]